Intratracheal instillation of budesonide suspension versus normal saline on oxidative stress in neonates with meconium aspiration syndrome

References

• Lee J, Romero R, Lee KA, et al. Meconium aspiration syndrome: a role for fetal systemic inflammation. Am J Obstet Gynecol. 2016;214(3):1 e361–8. doi: 10.1016/j.ajog.2015.10.009.
   PubMed Web of Science ®Google Scholar
• Natarajan CK, Sankar MJ, Jain K, et al. Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: a systematic review and meta-analysis. J Perinatol. 2016;36 Suppl 1(Suppl 1):S49–S54. (doi: 10.1038/jp.2016.32.
   PubMedGoogle Scholar
• Beligere N, Rao R. Neurodevelopmental outcome of infants with meconium aspiration syndrome: report of a study and literature review. J Perinatol. 2008;28 Suppl 3:S93–S101. doi: 10.1038/jp.2008.154.
   PubMed Web of Science ®Google Scholar
• Salvesen B, Stenvik J, Rossetti C, et al. Meconium-induced release of cytokines is mediated by the TRL4/MD-2 complex in a CD14-dependent manner. Mol Immunol. 2010;47(6):1226–1234. doi: 10.1016/j.molimm.2009.12.015.
   PubMed Web of Science ®Google Scholar
• Anand V, Basu S, Yadav SS, et al. Activation of toll-like receptors in meconium aspiration syndrome. J Perinatol. 2018;38(2):137–141. doi: 10.1038/jp.2017.169.
   PubMed Web of Science ®Google Scholar
• Schuliga M. NF-kappaB signaling in chronic inflammatory airway disease. Biomolecules. 2015;5(3):1266–1283. doi: 10.3390/biom5031266.
   PubMed Web of Science ®Google Scholar
• Kopincova J, Mikolka P, Kolomaznik M, et al. Selective inhibition of NF-kappaB and surfactant therapy in experimental meconium-induced lung injury. Physiol Res. 2017;66(Suppl 2):S227–S236. doi: 10.33549/physiolres.933678.
   PubMedGoogle Scholar
• Adcock IM, Mumby S. Glucocorticoids. Handb Exp Pharmacol. 2017;237:171–196. doi: 10.1007/164_2016_98.
   PubMedGoogle Scholar
• Tashkin DP, Lipworth B, Brattsand R. Benefit: risk profile of budesonide in obstructive airways disease. Drugs. 2019;79(16):1757–1775. doi: 10.1007/s40265-019-01198-7.
   PubMed Web of Science ®Google Scholar
• Mokra D, Mokry J, Drgova A, et al. Intratracheally administered corticosteroids improve lung function in meconium-instilled rabbits. J Physiol Pharmacol. 2007;58 Suppl 5(Pt 1):389–398.
   PubMedGoogle Scholar
• Kothe TB, Sadiq FH, Burleyson N, et al. Surfactant and budesonide for respiratory distress syndrome: an observational study. Pediatr Res. 2020;87(5):940–945. doi: 10.1038/s41390-019-0663-6.
   PubMed Web of Science ®Google Scholar
• Yeh TF, Chen CM, Wu SY, et al. Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2016;193(1):86–95. doi: 10.1164/rccm.201505-0861OC.
   PubMed Web of Science ®Google Scholar
• Yuksel M, Ustabas Kahraman F, Selek S, et al. Oxidant and antioxidant levels and DNA damage in tuberous sclerosis. Brain Dev. 2019;41(3):245–249. doi: 10.1016/j.braindev.2018.10.014.
   PubMed Web of Science ®Google Scholar
• Gandhi CK. Management of meconium-stained newborns in the delivery room. Neonatal Netw. 2018;37(3):141–148. doi: 10.1891/0730-0832.37.3.141.
   PubMedGoogle Scholar
• Zhu JX, Zhou XL, Zhang XD, et al. Analysis of clinical characteristics and death related factors of severe meconium aspiration syndrome-A multi-center retrospective survey. Chinese J Pract Pediatr. 2001;16(5):277–279.
   Google Scholar
• Huang Y. Clinical analysis of 612 meconium aspiration syndrome and their risk factors of complications [master’s thesis]. China: ChongQing Medical University; 2015. p. 1–39.
   Google Scholar
• Thornton PD, Campbell RT, Mogos MF, et al. Meconium aspiration syndrome: incidence and outcomes using discharge data. Early Hum Dev. 2019;136:21–26. (doi: 10.1016/j.earlhumdev.2019.06.011.
   PubMed Web of Science ®Google Scholar
• Haakonsen Lindenskov PH, Castellheim A, Saugstad OD, et al. Meconium aspiration syndrome: possible pathophysiological mechanisms and future potential therapies. Neonatology. 2015;107(3):225–230. doi: 10.1159/000369373.
   PubMed Web of Science ®Google Scholar
• Vidyasagar D, Zagariya A. Studies of meconium-induced lung injury: inflammatory cytokine expression and apoptosis. J Perinatol. 2008;28 Suppl 3:S102–S107. doi: 10.1038/jp.2008.153.
   PubMed Web of Science ®Google Scholar
• Mikolka P, Kopincová J, Košútová P, et al. Lung inflammatory and oxidative alterations after exogenous surfactant therapy fortified with budesonide in rabbit model of meconium aspiration syndrome. Physiol Res. 2016;65(Suppl 5):S653–S662. doi: 10.33549/physiolres.933529.
   PubMedGoogle Scholar
• Strandberg K, Blidberg K, Sahlander K, et al. Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils. Pulm Pharmacol Ther. 2010;23(4):316–323. doi: 10.1016/j.pupt.2010.03.004.
   PubMed Web of Science ®Google Scholar
• Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers. 2005;10 Suppl 1:S10–S23. doi: 10.1080/13547500500216546.
   PubMed Web of Science ®Google Scholar
• Zhang WB, Zhou SJ, Wang G, et al. Exhaled breath condensate 8-isoprostane of patients with or at risk for ARDS in ventilation. Chinese J Respiratory and Crit Care Med. 2018;17(1):66–70.
   Google Scholar
• Wu YX, Li XY. Research progress of 8-isoprostane in oxidative stress injury mechanism of respiratory disorders. Int J Respiration. 2019;39(18):1427–1430.
   Google Scholar
• Mikolka P, Kopincova J, Tomcikova Mikusiakova L, et al. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury. J Physiol Pharmacol. 2016;67(1):57–65.
   PubMed Web of Science ®Google Scholar
• Monfredini C, Cavallin F, Villani PE, et al. Meconium aspiration syndrome: a narrative review. Children (Basel). 2021;8(3):230. doi: 10.3390/children8030230.
   PubMed Web of Science ®Google Scholar
• Garg N, Choudhary M, Sharma D, et al. The role of early inhaled budesonide therapy in meconium aspiration in term newborns: a randomized control study. J Matern Fetal Neonatal Med. 2016;29(1):36–40. doi: 10.3109/14767058.2014.985202.
   PubMed Web of Science ®Google Scholar
• Sadeghnia A, Beheshti BK, Mohammadizadeh M. The effect of inhaled budesonide on the prevention of chronic lung disease in premature neonates with respiratory distress syndrome. Int J Prev Med. 2018;9(1):15. doi: 10.4103/ijpvm.IJPVM_336_16.
   PubMedGoogle Scholar